Help | RSS Feed

Luminex Corp. (NASD:LMNX) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Luminex Corp. (NASD:LMNX) seasonal charts above shows that a Buy Date of April 24 and a Sell Date of September 15 has resulted in a geometric average return of 12.6% above the benchmark rate of the S&P 500 Total Return Index over the past 19 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 19 years by an average of 18.4% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Luminex Corp is a United States based company that develops, manufactures and sells proprietary biological testing technologies and products with applications throughout the life sciences industries, including diagnostics, pharmaceutical, and research. Its products include MAGPIX, Luminex 100/200, and FLEXMAP 3D. Their key market segments are molecular infectious disease, genetic or inherited disease, human leukocyte antigen (HLA) transplant diagnostics, immunodiagnostics, and life sciences research. It offers various solutions in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety.

To download LMNX seasonal chart data, please log in or Subscribe.


Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z